Alex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to
The Prototype: King Tut’s Curse Might Kill Leukemia
In this week’s edition of The Prototype, we look at cancer-killing fungi, robots that perform surgery on your eyeballs, genetically modified bacteria that turn plastic into Tylenol and more.
InnovationRx: Health Insurers Vow To Improve Prior Authorization (Again)
In this week’s edition of InnovationRx, we look at health insurers' vows to improve prior authorization, Bell Labs’ IP commercialization, a new healthcare billionaire, a robot performing cataract surgery, and more.
InnovationRx: The Dangers Of RFK Jr.’s Vaccine Advisory Committee
In this week’s edition of InnovationRx, we look at the dangers of RFK Jr.’s vaccine advisory committee, how Trump’s visa ban bars foreign doctors, the first FDA-approved transcontinental telesurgery, and more.
The Prototype: Space Company Voyager’s Stock Soars On IPO
In this week’s edition of The Prototype, we look at a big space stock IPO, Korea’s plan to dominate the world of robots, building electric motors without metal and more.
InnovationRx: RFK Jr. Purges The Vaccine Advisory Committee
In this week’s edition of InnovationRx, we look at RFK Jr.’s vaccine advisory committee purge, a tech billionaire’s funding of research on AI and healthcare, Omada’s IPO and more.
The Prototype: This AI Model Could Make It Faster To Find New Medicines
In this week’s edition of The Prototype, we look at a new AI model that could speed up drug discovery, how the Trump/Musk blowup could impact NASA, a new class of electronics and more.
NASA Missions Could Be The Biggest Casualty Of The Trump/Musk Feud
The space agency relies on Elon Musk’s rockets for crucial missions to the International Space Station. Who will replace them when competitors are still playing catch up?
InnovationRx: Trump’s Proposed Budget Slashes Biomedical Research
In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and global health, news from the ASCO cancer meeting, Summit Therapeutics’ Maky Zanganeh and more.
The Prototype: China Tries To Attract The Researchers America Is Turning Away
In this week’s edition of The Prototype, we look at a 4-D approach to quantum computing, a drug combination that could lead to healthy aging and more.
InnovationRx: Hinge May Herald A New Wave Of Digital Health IPOs
In this week’s edition of InnovationRx, we look at how Hinge Health’s successful IPO may be a trendsetter, Indian billionaire Kiran Mazumdar-Shaw’s ‘biosimilars’ business, RFK’s changes to Covid vaccine guidance and more.